Healthcare budget
The Centre on Friday approved Bharat Biotech’s needle-free intranasal Covid vaccine for booster dose, said an official source.
The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
The source said that Nasal vaccine will be used as a heterologous booster among eligible population. Meanwhile, the intranasal Covid vaccine is also expected to be introduced in the COVID19 vaccination program from today, said the source.
The nasal vaccine is likely to be added to the CoWIN App from today.
Meanwhile, India on Friday reported 163 fresh COVID-19 cases along with 9 deaths have also been reported in the country. The number of active coronavirus cases declines to 3,380.
Paras Health has launched Paras Medi Clinic, a community-focused healthcare initiative and Gurugram’s neighbourhood clinic…
In a unique case of showing spirit of Raksha Bandhan, a 24-year-old man has saved…
The national capital reported 138 H1N1 cases in the last 24 hours, taking the cumulative…
The Central Government has imposed restrictions on the manufacture, sale, and distribution of all fixed-dose…
Addressing the 2nd ICC Medical Education Forum, organised by the Indian Chamber of Commerce (ICC) in association…
The National Medical Commission has proposed a centrally generated unique identification number for every registered…